Trial Site Detail

 

Drug:
Imatinib
Trial:
Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

Orebro University Hospital, Örebro

     
Orebro ,
Sweden

 

Principal Investigator:
Contact:
Activation Status of this Site:
Active
Notes about this Site:
Orebro University Hospital, Örebro Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.